| Literature DB >> 36220953 |
Marco Antonio Silveira Santos1, Alexia Guimarães Ramos1, Thiago Carvalho de Sousa1, Rodrigo Antonio de Medeiros2,3.
Abstract
OBJECTIVE: Assess the prevalence of self-reported TMD symptoms and anxiety and check the quality of sleep and life during the distance learning period in university students at the University of Brasilia (UnB).Entities:
Keywords: Anxiety; Anxiety disorders; COVID-19; Myalgia; Temporomandibular disorders
Year: 2022 PMID: 36220953 PMCID: PMC9553078 DOI: 10.1007/s00784-022-04743-z
Source DB: PubMed Journal: Clin Oral Investig ISSN: 1432-6981 Impact factor: 3.606
Frequency (percentage) of study participants regarding the association between TMD symptoms and different analyzed variables (Chi-square, P < 0.05)
| Variables | TMD symptoms | ||||
|---|---|---|---|---|---|
| No TMD | Nonpainful TMD | Painful TMD | |||
| Gender | Male | 15 (36.5%) | 9 (22%) | 17 (41.5%) | 0.175 |
| Female | 27 (23.5%) | 22 (19.1%) | 66 (57.4%) | ||
| Anxiety symptoms | None | 10 (40%) | 6 (24%) | 9 (36%) | 0.007* |
| Mild | 16 (27.1%) | 16 (27.1%) | 27 (45.8%) | ||
| Moderate | 12 (29.3%) | 8 (19.5%) | 21 (51.2%) | ||
| Severe | 4 (12.9%) | 1 (3.2%) | 26 (83.9%) | ||
| Sleep quality | Good | 15 (39.5%) | 10 (26.3%) | 13 (34.2%) | 0.081 |
| Bad | 22 (22.4%) | 19 (19.4%) | 57 (58.2%) | ||
| Sleep disturbance | 5 (25%) | 2 (10%) | 13 (65%) | ||
| Course period | Begining | 7 (28%) | 3 (12%) | 15 (60%) | 0.411 |
| Middle | 22 (26.8%) | 14 (17.1%) | 46 (56.1%) | ||
| Final | 13 (26.5%) | 14 (28.6%) | 22 (44.9%) | ||
*P < 0.05
The mean values (standard deviation) of TMD symptoms in relation to WHOQoL-bref domains score
| WHOQOL-Bref | TMD symptoms | ||
|---|---|---|---|
| No TMD | Nonpainful TMD | Painful TMD | |
| Domain I (Physical)* | 67.94 (14.51)A | 66.24 (15.86)AB | 59.42 (16.54) B |
| Domain II (Psycological)** | 61.40 (18.17)A | 53.56 (17.65)AB | 61.96 (12.25)B |
| Domain III (Social relations)** | 60.31 (24.74)A | 57.93 (21.10)A | 68.01 (17.09)A |
| Domain IV (Enviromental)* | 61.60 (19.24)A | 59.90 (17.43)A | 64.91 (15.92)A |
Different capital letters indicate difference between groups P < 0.05
*One-Way ANOVA and Bonferroni’s Test
**Kruskal–Wallis and Dunn’s test
The mean values (standard deviation) of anxiety symptoms in relation to WHOQoL-bref domains score
| WHOQOL-Bref | Anxiety symptoms | |||
|---|---|---|---|---|
| None | Mild | Moderate | Severe | |
| Domain I (Physical)* | 76.71 (12.63)A | 67.13 (14.20)B | 60.10 (12.49)B | 48.27 (14.69)C |
| Domain II (Psycological)** | 73.16 (11.72)A | 62.21 (12.35)B | 53.04 (14.73)C | 40.99 (16.94)D |
| Domain III (Social relations)** | 74 (19.59)A | 64.97 (18.55)B | 57.52 (19.07)C | 45.43 (22.95)D |
| Domain IV (Enviromental)* | 73.25 (12.30)A | 64.88 (14.69)AB | 57.69 (17.07)BC | 49.89 (19.65)C |
Different capital letters indicate difference between groups P < 0.05
*One-Way ANOVA and Bonferroni’s Test
**Kruskal–Wallis and Dunn’s test
The mean values (standard deviation) of sleep quality in relation to WHOQoL-bref domains score
| WHOQOL-Bref | Sleep quality | ||
|---|---|---|---|
| Good | Bad | Sleep disturbance | |
| Domain I (Physical)* | 76.69 (12.25)A | 61.80 (13.55)B | 43.39 (11.94)C |
| Domain II (Psycological)** | 71.05 (9.87)A | 55.35 (16.04)B | 41.04 (15.78)C |
| Domain III (Social relations)** | 70.61 (18.25)A | 58.58 (21.48)B | 51.25 (22.50)B |
| Domain IV (Enviromental)* | 69.81 (12.33)A | 60.29 (17.05)AB | 50.46 (20.20)B |
Different capital letters indicate difference between groups P < 0.05
*One-Way ANOVA and Bonferroni’s Test
**Kruskal–Wallis and Dunn’s test